ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HIK Hikma Pharmaceuticals Plc

1,934.00
-20.00 (-1.02%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -1.02% 1,934.00 1,925.00 1,926.00 1,956.00 1,919.00 1,955.00 145,039 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 22.25 4.34B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,954p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,722.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.34 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.25.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1551 to 1573 of 1875 messages
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older
DateSubjectAuthorDiscuss
29/4/2022
07:31
Market does not like it obviously.Still two more tranches of buybacks, one just started. At least more shares for the buybacks with the price fall.
montyhedge
29/4/2022
07:06
All on track, generics growth 8% to 10% margins 24% to 25%.But market always want more. Strong cash generation continues. Forecast 2022 p.e 12.2. Hikma is always the Cinderella of the pharma sector on a low rating.
montyhedge
29/4/2022
06:39
Robertball: No idea, both sound OK to me. It's all relative, it depends on what the market was expecting. But increased dividend, increased profits, and growth sound OK to me....

Its probably good (touchwood)

netcurtains
29/4/2022
06:21
Injectables good. Generics poor??
robertball
28/4/2022
11:38
including MCRO?
phillis
28/4/2022
11:04
Pound weak again, talk of $1.20 to the pounds, boost Hikma and dividend payments. All U.K. dollar earners I think would benefit.
montyhedge
27/4/2022
12:03
Still cheaper the shareprice more they can buyback.
montyhedge
25/4/2022
18:48
But would hit UK oil price and be inflationary
robertball
25/4/2022
16:56
Standard Bank analyst said pound could go to $1.20 to pound, nice boost for Hikma if that happens.
montyhedge
22/4/2022
07:35
The weak pound good for U.K. dollar earners, who report in dollars, bigger dividends when converted into sterling.
montyhedge
21/4/2022
15:33
Where would this dog be without the buyback??
blue59
20/4/2022
08:25
No I am MH, honest. Thanks for the info.
netcurtains
20/4/2022
08:18
Custompharm takeover been given the green light in the US.Hikma growing, but market not interested it seems.
montyhedge
20/4/2022
08:07
Odd response from mr market. Wonder who is selling - share price would be above 3000p by now
scepticalinvestor
18/4/2022
17:08
Astra and Hikma the two shares to buy, to be on the same page as Astra that’s nice, lol.
montyhedge
14/4/2022
09:04
I don't think so no rns. I just think investors think this safe boring 15 years of continuous dividend growth, is not exciting like say Astra or other pharma stocks.
montyhedge
13/4/2022
11:06
Must be a substantial holder dumping
scepticalinvestor
13/4/2022
08:10
Buybacks continues shareprice not moving at least they are buying back cheap, normally companies having buybacks pay top price.
montyhedge
10/4/2022
10:25
British Bulls made this a buy on Friday:
netcurtains
08/4/2022
11:13
Once again the Cinderella of the Pharma lagging behind, one day Cinders will join the ball. Forecast p.e 12.2.
montyhedge
08/4/2022
07:41
Its working for GSK on most days (and also it appears to be working for PEARSON).
I'm thinking SI, it probably will work for HIK too... Touchwood!

netcurtains
08/4/2022
07:18
Share buyback not exactly working lol
scepticalinvestor
04/4/2022
11:31
According to this article forecast forward p.e 12.2, if correct that is ridiculously cheap for a FTSE 100 pharma stock.https://www.fool.co.uk/2022/02/18/2-cheap-uk-stocks-to-buy-for-the-rotation-into-value/
montyhedge
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older

Your Recent History

Delayed Upgrade Clock